Could you have sleep apnea?

Jillian Foglesong Stabile, MD

FAAFP, DABOM · Reviewed June 10, 2026 · STOP-BANG, Chung 2012

Question 1 of 8

Do you snore loudly, loud enough to be heard through closed doors or for a bed partner to elbow you?

A screening tool, not a diagnosis. OSA diagnosis requires a sleep study interpreted by a physician. Tirzepatide (Zepbound®) is a trademark of its owner; sipra is not affiliated with it. A physician determines whether evaluation or treatment is indicated. Individual results vary.

Chapter 01 · The screener

What the STOP-BANG letters mean

The STOP-BANG name encodes its 8 items: Snoring (loud), Tiredness (daytime), Observed (apneas), blood Pressure (high), BMI (over 35), Age (over 50), Neck (over 40 cm), and being assigned male at birth. Each yes adds one point, and the total is your score.¹ The instrument was originally validated in surgical patients before anesthesia, but it has since been validated across primary care, sleep clinics, and population screening. It is built to be sensitive, so it deliberately catches more people than truly have OSA.

Chapter 02 · The metabolic link

Why OSA matters for weight loss

This is the connection most patients do not know about. Untreated OSA produces nocturnal low oxygen, fragmented sleep, and elevated cortisol, all of which promote insulin resistance. Multiple studies show that treating OSA with continuous positive airway pressure (CPAP) improves metabolic markers, and untreated OSA can make weight loss harder. Notably, tirzepatide (Zepbound®) is FDA-approved to treat moderate-to-severe OSA, so the two conditions are often addressed together. For someone pursuing weight loss who also screens positive on STOP-BANG, addressing OSA in parallel often produces better outcomes than treating either alone.

Severity	AHI range	What it means
Mild OSA	AHI 5 to 14	Fewest breathing events per hour
Moderate OSA	AHI 15 to 29	A common treatment threshold
Severe OSA	AHI 30 or more	Most breathing events per hour

Severity is graded by the apnea-hypopnea index (AHI), the average breathing events per hour on a sleep study.

Chapter 03 · The diagnosis

How OSA is actually diagnosed

A high STOP-BANG score is a pre-test probability, not a diagnosis. The diagnosis requires objective sleep testing: in-lab polysomnography, the gold standard, or a home sleep apnea test (HSAT).³ HSAT is appropriate for adults with a high pre-test probability of moderate-to-severe OSA and no significant comorbidities. The result is reported as the apnea-hypopnea index, and severity follows the table below.

STOP-BANG score	Risk band	What it suggests
0 to 2	Low	Low probability of moderate-to-severe OSA
3 to 4	Intermediate	Physician evaluation is appropriate
5 to 8	High	Evaluation and likely a sleep study are warranted

A negative screen does not rule out OSA when symptoms are strong; clinical judgment supersedes the score.

Chapter 04 · The options

Treatments for confirmed OSA

First-line treatment is positive airway pressure (CPAP, BiPAP, APAP), which is highly effective with consistent use. Mandibular advancement devices are an alternative for mild-to-moderate OSA. Weight loss has a dramatic effect in many patients with obesity and OSA, sometimes allowing CPAP weaning. Positional therapy, hypoglossal nerve stimulation, and upper airway surgery are options for selected patients. Treatment selection follows the sleep study and is made with a sleep medicine physician.

STOP-BANG is a starting signal, not a verdict. A high score is a reason to begin a workup with a physician, and a sleep study confirms or rules out OSA. Individual results vary.

Every medication on sipra is prescribed by a licensed physician, so your care always starts with a visit. Your sipra membership gives you ongoing access to those physician visits, so you can check in, adjust your plan, and ask questions whenever you need, without paying per visit. It is how we keep high-quality care convenient: one membership, physician access whenever you need it, and support at every step.

A STOP-BANG score of 5 or higher means a high probability of moderate-to-severe obstructive sleep apnea. It is a screening result, not a diagnosis. OSA diagnosis requires objective sleep testing, either in-lab polysomnography or a validated home sleep apnea test, interpreted by a sleep medicine physician. A high STOP-BANG score should be the start of a workup, not the end. Individual results vary.

Untreated OSA produces nocturnal hypoxia, sleep fragmentation, and elevated cortisol, all of which promote insulin resistance. Multiple studies have shown that treating OSA with CPAP improves metabolic markers, and untreated OSA can make weight loss harder. Tirzepatide (Zepbound) is FDA-approved to treat moderate-to-severe OSA, so the two conditions are often co-managed. Co-managing OSA and obesity often produces better outcomes than treating either alone.

A home sleep apnea test is a portable diagnostic device worn overnight at home that measures breathing, oxygen, and heart rate. It is appropriate for adults with a high pre-test probability of moderate-to-severe OSA and no significant comorbidities. For lower pre-test probability, atypical symptoms, or comorbidities such as heart failure, COPD, or neuromuscular disease, in-lab polysomnography remains the gold standard.

First-line treatment is positive airway pressure (CPAP, BiPAP, APAP), which is highly effective when used consistently. Alternatives include mandibular advancement devices for mild-to-moderate OSA, weight loss, positional therapy if OSA is position-dependent, and in select cases hypoglossal nerve stimulation or upper airway surgery. Treatment selection follows the sleep study results and is made with a sleep medicine physician.

Sources

Chung F, Yegneswaran B, Liao P, et al. "STOP questionnaire: a tool to screen patients for obstructive sleep apnea." Anesthesiology. 2008;108(5):812-21. doi.org
Chung F, Subramanyam R, Liao P, et al. "High STOP-Bang score indicates a high probability of obstructive sleep apnea." Br J Anaesth. 2012;108(5):768-75. doi.org
Kapur VK, Auckley DH, Chowdhuri S, et al. "Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea." J Clin Sleep Med. 2017;13(3):479-504. doi.org

Compounded medications are not FDA-approved and require a patient-specific prescription. Brand names are trademarks of their owners; sipra is not affiliated with them.

General education, not medical advice. Last reviewed June 10, 2026 by Jillian Foglesong Stabile, MD, FAAFP, DABOM. Prices snapshot STOP-BANG, Chung 2012. Individual results vary.